CIBC (CM) Innovation Banking provided growth capital financing for EnsoData, a leading provider of AI-powered software solutions for sleep medicine. EnsoData is advancing sleep medicine through AI-powered, FDA-cleared solutions that help simplify diagnosis and expand access to care. Its flagship product, EnsoHST, is a clinically proven, multi-night home sleep testing solution that uses a simple wearable device and mobile app to deliver fast, clinically reliable results. By automating analysis and removing operational friction, EnsoData enables clinicians to expand capacity, accelerate diagnosis, and improve patient outcomes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CM:
- CIBC price target raised to C$159 from C$153 at Scotiabank
- CIBC Innovation Banking provides EUR 10M in financing to Qover
- CIBC Shareholders Re-Elect Full Slate of Directors at 2026 Annual Meeting
- CIBC Innovation Banking serves as lead arranger for Vena credit facility
- Major Canadian banks met to discuss Anthropic cybersecurity risk, Bloomberg says